Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-043931
Filing Date
2024-11-07
Accepted
2024-11-07 09:00:46
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1319500
2 ex10-5.htm EX-10.5 10223
3 ex31-1.htm EX-31.1 19410
4 ex31-2.htm EX-31.2 19422
5 ex32-1.htm EX-32.1 8286
6 ex10-5_001.jpg GRAPHIC 518107
7 ex10-5_002.jpg GRAPHIC 512603
8 ex10-5_003.jpg GRAPHIC 452639
9 ex10-5_004.jpg GRAPHIC 486148
10 ex10-5_005.jpg GRAPHIC 596206
11 ex10-5_006.jpg GRAPHIC 497755
12 ex10-5_007.jpg GRAPHIC 504962
13 ex10-5_008.jpg GRAPHIC 510976
14 ex10-5_009.jpg GRAPHIC 390061
15 ex10-5_010.jpg GRAPHIC 121084
  Complete submission text file 0001493152-24-043931.txt   11808957

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE imnn-20240930.xsd EX-101.SCH 34228
17 XBRL CALCULATION FILE imnn-20240930_cal.xml EX-101.CAL 48427
18 XBRL DEFINITION FILE imnn-20240930_def.xml EX-101.DEF 132138
19 XBRL LABEL FILE imnn-20240930_lab.xml EX-101.LAB 347708
20 XBRL PRESENTATION FILE imnn-20240930_pre.xml EX-101.PRE 264274
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 806810
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 241433432
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)